New cytochrome P450 mechanisms: implications for understanding molecular basis for drug toxicity at the level of the cytochrome.

Expert Opinion on Drug Metabolism & Toxicology
Narasimhulu Shakunthala

Abstract

Cytochrome (CYP) P450 is a collective name for a very large group of heme enzymes, which catalyze largely oxidative reactions, including those of pharmacological and toxicological importance. Their efficient operation requires coupling of specific electron donor and O(2) consumption and substrate hydroxylation. Many drug oxidation reactions are partially uncoupled, leading to the formation of highly toxic reactive oxygen species, which can cause unpredictable toxic effects on the cell. Rational approaches to avoid uncoupling require knowledge of the underlying mechanisms. In this communication, attempts have been made to bring together past as well as present information indicating that i) the P450 active site has two differently accessible allosterically interacting subsites geared for entirely different types of functionally relevant interactions; and ii) substrate binding to the specific protein residues (Site I) forming the reducible high-spin complex and product binding at L(6) (Site II) of the heme iron forming inhibited low-spin complex can regulate the functional state of the enzyme during catalysis. Since P450 enzymes catalyze a wide variety of reactions, understanding the molecular basis for their efficient operation ...Continue Reading

References

Aug 14, 1978·Biochemical and Biophysical Research Communications·J D LipscombI C Gunsalus
Jan 6, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T L Poulos, R Raag
Jun 5, 1987·Journal of Molecular Biology·T L PoulosA J Howard
Jan 6, 1995·The Journal of Biological Chemistry·R Taussig, A G Gilman
Mar 8, 1995·Biochemical and Biophysical Research Communications·Y KimataY Ishimura
Jan 14, 1997·Biochemistry·Y F UengF P Guengerich
Mar 4, 2000·Science·I SchlichtingS G Sligar
Jun 22, 2000·The Journal of Biological Chemistry·J K YanoT L Poulos
Jul 27, 2001·Current Drug Metabolism·W Tang, R A Stearns
Mar 20, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Matthew Hutzler, Timothy S Tracy
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Aleksandra GaletinJ Brian Houston
Feb 1, 2003·Archives of Biochemistry and Biophysics·J Matthew HutzlerTimothy S Tracy
Aug 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Aleksandra GaletinJ Brian Houston
Oct 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Emily E ScottC David Stout
Nov 25, 2003·Biochemical and Biophysical Research Communications·Minor J Coon
Jul 20, 2004·The Journal of Biological Chemistry·Jason K YanoEric F Johnson
Apr 16, 2005·Annual Review of Pharmacology and Toxicology·William M Atkins
Sep 28, 2005·Biochemical and Biophysical Research Communications·Thomas L Poulos
Sep 6, 2007·Drug Metabolism Reviews·Thomas L Poulos
Jan 17, 2009·Biochemistry·Hugues OuelletPaul R Ortiz de Montellano

❮ Previous
Next ❯

Citations

Nov 2, 2011·Internal and Emergency Medicine·Teresita Mazzei
May 29, 2013·SAR and QSAR in Environmental Research·T FerrariE Benfenati
May 22, 2013·Oxidative Medicine and Cellular Longevity·Byoung-Joon SongKwan-Hoon Moon
Mar 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·Romualdo Benigni
Aug 15, 2013·Expert Opinion on Drug Metabolism & Toxicology·Tewes Tralau, Andreas Luch
Jan 28, 2012·Biochimica Et Biophysica Acta·Joep P J de HoonVivianne C G Tjan-Heijnen
Feb 1, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A CorsonelloF Lattanzio
Jan 22, 2013·Journal of Molecular Recognition : JMR·Maria S ZharkovaAlexander I Archakov
Apr 5, 2014·SAR and QSAR in Environmental Research·C A CarrasquerS L Cunningham
Jan 20, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roberta BerniniSandra Incerpi
Nov 12, 2010·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Romualdo BenigniOlga Tcheremenskaia
May 3, 2011·Archives of Toxicology·Sarah AdlerJosé-Manuel Zaldivar
Sep 25, 2020·Scientific Reports·Javier Gómez-TabalesCarlos Gutierrez-Merino
May 29, 2010·Toxicology Mechanisms and Methods·Hailong ZhouQinzhao Xue
Jan 23, 2020·Journal of Medicinal Chemistry·William C WrightTaosheng Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.